Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years
| Main Authors: | , , , , |
|---|---|
| Format: | Journal article |
| Sprog: | English |
| Udgivet: |
Public Library of Science
2018
|
| _version_ | 1826286141074046976 |
|---|---|
| author | Olliaro, P Kuesel, A Halleux, C Sullivan, M Reeder, J |
| author_facet | Olliaro, P Kuesel, A Halleux, C Sullivan, M Reeder, J |
| author_sort | Olliaro, P |
| collection | OXFORD |
| description | |
| first_indexed | 2024-03-07T01:39:22Z |
| format | Journal article |
| id | oxford-uuid:9653b6f7-33e0-4e3f-a914-5c6e82cdcef3 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-07T01:39:22Z |
| publishDate | 2018 |
| publisher | Public Library of Science |
| record_format | dspace |
| spelling | oxford-uuid:9653b6f7-33e0-4e3f-a914-5c6e82cdcef32022-03-26T23:52:08ZCreative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 yearsJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:9653b6f7-33e0-4e3f-a914-5c6e82cdcef3EnglishSymplectic Elements at OxfordPublic Library of Science2018Olliaro, PKuesel, AHalleux, CSullivan, MReeder, J |
| spellingShingle | Olliaro, P Kuesel, A Halleux, C Sullivan, M Reeder, J Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years |
| title | Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years |
| title_full | Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years |
| title_fullStr | Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years |
| title_full_unstemmed | Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years |
| title_short | Creative use of the priority review voucher by public and not-for-profit actors delivers the first new FDA-approved treatment for river blindness in 20 years |
| title_sort | creative use of the priority review voucher by public and not for profit actors delivers the first new fda approved treatment for river blindness in 20 years |
| work_keys_str_mv | AT olliarop creativeuseofthepriorityreviewvoucherbypublicandnotforprofitactorsdeliversthefirstnewfdaapprovedtreatmentforriverblindnessin20years AT kuesela creativeuseofthepriorityreviewvoucherbypublicandnotforprofitactorsdeliversthefirstnewfdaapprovedtreatmentforriverblindnessin20years AT halleuxc creativeuseofthepriorityreviewvoucherbypublicandnotforprofitactorsdeliversthefirstnewfdaapprovedtreatmentforriverblindnessin20years AT sullivanm creativeuseofthepriorityreviewvoucherbypublicandnotforprofitactorsdeliversthefirstnewfdaapprovedtreatmentforriverblindnessin20years AT reederj creativeuseofthepriorityreviewvoucherbypublicandnotforprofitactorsdeliversthefirstnewfdaapprovedtreatmentforriverblindnessin20years |